Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Revolution Peripheral Atherectomy System

K-Number: K212351 · 2021-12-15

ApplicantRex Medical, L.P.
Decision Date2021-12-15
Product CodeMCW
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Revolution Peripheral Atherectomy System is a medical device manufactured by Rex Medical, L.P.. It received FDA 510(k) clearance on 2021-12-15 under approval number K212351. The device is classified under product code MCW. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Revolution Peripheral Atherectomy System?

Revolution Peripheral Atherectomy System is a medical device that received FDA 510(k) clearance on 2021-12-15. It is manufactured by Rex Medical, L.P.. The 510(k) number is K212351.

When was Revolution Peripheral Atherectomy System approved by the FDA?

Revolution Peripheral Atherectomy System received FDA 510(k) clearance on 2021-12-15, under approval number K212351.

What company makes Revolution Peripheral Atherectomy System?

Revolution Peripheral Atherectomy System is manufactured by Rex Medical, L.P..

What is the FDA product code for Revolution Peripheral Atherectomy System?

The FDA product code for Revolution Peripheral Atherectomy System is MCW.

Related Clinical Trials

NCT06727942 Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes RECRUITING NCT04246281 The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain COMPLETED NCT07606196 The Effect of Otolith Dysfunction and Its Rehabilitation in Vestibular Diseases COMPLETED NCT05150197 Virtual Reality Visual Field Testing as an Alternative in Childhood Eye Disease RECRUITING NCT00453505 Modulation of Motor Function by Stimulation of the Central and Peripheral Nervous System COMPLETED NCT04229563 Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease COMPLETED

Related PubMed Literature

PMID: 40077817 Research Progress on Neural Cell Culture Systems. Current neuropharmacology (2025)

Other Devices by Rex Medical, L.P.

K173389Rex Medical Aspiration Pump K191419Revolution Peripheral Atherectomy System, Revolution Peripheral Atherectomy Guidewire PMA P150022Device, hemostasis, vascular

Related Devices (Code: MCW)

K163264Pantheris Catheter (8F); Pantheris Cather (7F); Lightbox HS Imaging Console; Lightbox SledAvinger, Inc. K162326Pantheris Catheter, Lightbix HS Imaging Console, Lightbox SledAvinger, Inc. K161361HawkOne Directional Atherectomy SystemMedtronic Vascular, Inc. K160827Pantheris CatheterAvinger, Inc. K153460Pantheris Catheter (8Fr), Pantheris Catheter (7Fr)Avinger, Inc. K172687Turbo-Power (2.0mm) Laser Atherectomy Catheters, Turbo-Power (2.3mm) Laser Atherectomy CathetersSpectranetics, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑